The Mutual Fund Show: Why Pharma And I.T. Funds Remain Good Investment Options

Pharmaceutical and technology stocks have gained this year as the coronavirus pandemic led to an increase in demand for certain drugs and prompted companies to adapt to digital transformation. While average category returns of open-ended pharma funds in the last one year have been close to 61%, those of […]

Click here to view original web page at www.bloombergquint.com